The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine

Prenatal Diagnosis

Volumn 33, Issue 3, 2013, Pages 242-244

  Rose, Nancy C ^a,b   Lagrave, Danielle ^a,c   Hafen, Brent ^a   Jackson, Marc ^a,b  

^a INTERMOUNTAIN HEALTHCARE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; FIRST TRIMESTER PREGNANCY; GENETICS; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; OBSTETRICS; PRENATAL SCREENING; PRIORITY JOURNAL;

AMNIOCENTESIS; ANEUPLOIDY; BIOLOGICAL MARKERS; FEMALE; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; OBSTETRICS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; TERTIARY CARE CENTERS;

EID: 84874510427     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4052     Document Type: Article

References (15)

1. Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-11.
2. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999;341:461-7.
3. Palomaki GE, Kloza EM Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011:913-20.
4. Enrich M, Decia C, Zwiefelhofer T, et al. Non invasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1-11.
5. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
6. Norton ME, Brar H, Weiss J, et al. Non-invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207(2):137.e1-8.
7. Haddow JE, Palomaki GE, Knight GJ, et al. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. NEJM 1994;330:1114-8.
8. Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. NEJM 2012;367:2175-84.
9. American Congress of Obstetricians and Gynecologists. ACOG Practice Bulletin #107: induction of labor. Obstet Gynecol 2009;114:386-97.
10. Tabor A, Philip J, Madsen M, et al. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986;1(8493):1287.
11. Odibo AO, Gray DL, Dicke JM, et al. Revisiting the fetal loss rate after genetic amniocentesis. Obstet Gynecol 2008;111:589-95.
12. Eddleman KA, Malone FD, Sullivan L, et al. Pregnancy loss rates after amniocentesis. Obstet Gynecol 2006;108:1067-72.
13. Smith JF, Bergmann M, Gildersleeve R, Alle R. A simple model for learning sterotactic skills in ultrasound-guided amniocentesis. Obstet Gynecol 1998;92:303-5.
14. Zubair I, Marcotte MP, Weinstein L, Brost B. A novel amniocentesis model for learning stereotactic skills. Am J Obstet Gynecol 2006;194:846-8.
15. Pittini R, Oepkess d, Macrury K, Reznick R, Beyene J, Windrim R. Teaching invasive perinatal procedures: assessment of a high fidelity simulator based curriculum. Ult Obstet Gynecol 2002;19:478-83.